If you need more lookups,
subscriptions start at $34 USD/month.
Darby Thomas Location
Durham, NC, US
Darby Thomas Work
2023 -now Scientific Director, Gene Therapies, Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT) @
2021 -2023 Director, Enterprise Cell and Gene Therapy @
2021 -2021 VP, Early Development @ Sio Gene Therapies
2019 -2021 Head Patient Advocacy and Engagement @
2018 -2021 VP, Preclinical Development @
2018 -2018 Director, Program and Project Management @ Precigen Inc., a subsidiary of Intrexon Corp.
2016 -2017 Director, Rare Diseases @
2014 -2016 Associate Director, Rare Diseases @
2012 -2014 Program Lead, Research Operations Group @
2010 -2012 Translational Scientist @
2004 -2010 Scientist I-III @
2000 -2004 Postdoctoral Fellow @
Darby Thomas Education
Baylor College of Medicine 1993-1999
The University of North Carolina at Chapel Hill 1989-1993
Darby Thomas Skills
Gene Therapy
Process Development
Translational Research
Assay development and transfer
Virology
Project Management
Cell
Assay Development
qPCR
Molecular Biology
Cell Culture
DNA
Science
Clinical Development
Biotechnology
Microbiology
Translational Medicine
Cancer
Antibodies
Vaccines
Real Time Polymerase Chain Reaction Qpcr
Flow Cytometry
Sop
Cell Biology
Public Speaking
Biochemistry
Immunoassays
Management
Data Analysis
Research
Technology Transfer
Life Sciences
VA
Real Time Polymerase Chain Reaction
Darby Thomas Summary
Darby Thomas, based in Durham, NC, US, is currently a Scientific Director, Gene Therapies, Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT) at Fortrea. Darby Thomas brings experience from previous roles at Labcorp Drug Development, Sio Gene Therapies and StrideBio, Inc. Darby Thomas holds a 1993 - 1999 Baylor College of Medicine. With a robust skill set that includes Gene Therapy, Process Development, Translational Research, Assay development and transfer, Virology and more. Darby Thomas has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Darby Thomas?
Find contact details for 700 million professionals.